Cargando…
A first census of skin cancer specialist nurses across UK secondary care trusts
BACKGROUND: Skin cancer specialist nurses (SCSNs) support patients and work alongside healthcare professionals throughout the care pathway. Skin cancer management is rapidly evolving, with increasing and more complex treatment options now available, so the need for patient support is growing. While...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290789/ https://www.ncbi.nlm.nih.gov/pubmed/37355649 http://dx.doi.org/10.1186/s12912-023-01374-x |
_version_ | 1785062565447991296 |
---|---|
author | Rammanohar, Jashmitha Kotecha, Deeya Hodgetts, Jackie Reeken, Saskia Daniels, Susanna Corrie, Pippa G |
author_facet | Rammanohar, Jashmitha Kotecha, Deeya Hodgetts, Jackie Reeken, Saskia Daniels, Susanna Corrie, Pippa G |
author_sort | Rammanohar, Jashmitha |
collection | PubMed |
description | BACKGROUND: Skin cancer specialist nurses (SCSNs) support patients and work alongside healthcare professionals throughout the care pathway. Skin cancer management is rapidly evolving, with increasing and more complex treatment options now available, so the need for patient support is growing. While SCSNs are a major source of that support, the provision of SCSN resource across the UK has never previously been assessed. We therefore undertook a first SCSN census on 1st June 2021. METHODS: An electronic survey was disseminated to UK hospital trusts and registered skin cancer healthcare professionals. Responses were identifiable only by the respective trust name. RESULTS: 112 responses from 87 different secondary care trusts were received; 92% of trusts reporting having at least 1 established SCSN post. Average SCSN staffing per trust was 2.4 (range 0–7) whole time equivalents, managing an average caseload of 83 (range 6–400) patients per week. SCSN workload had increased in 82% hospitals in the previous year and 30% of trusts reported being under-resourced. Most SCSN time was spent managing melanoma (as opposed to non-melanoma skin cancer) patients linked to surgical services. Regional variations existed, particularly associated with provision of lymphoedema services, nurse prescribing skills and patient access to clinical trials. The COVID-19 pandemic was associated with a marked increase in SCSN-led telemedicine clinics, but loss of training and education opportunities. CONCLUSIONS: SCSNs based in secondary care hospitals play a major role supporting both clinicians and patients throughout the care pathway. This first UK census confirmed that SCSN workload is increasing and in one third of hospital trusts, the work was reported to outstrip the staffing available to manage the volume of work. Regional variations in SCSN resource, workload and job role, as well as availability of certain skin cancer services were identified, providing valuable information to healthcare commissioners concerned with service improvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12912-023-01374-x. |
format | Online Article Text |
id | pubmed-10290789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102907892023-06-26 A first census of skin cancer specialist nurses across UK secondary care trusts Rammanohar, Jashmitha Kotecha, Deeya Hodgetts, Jackie Reeken, Saskia Daniels, Susanna Corrie, Pippa G BMC Nurs Research BACKGROUND: Skin cancer specialist nurses (SCSNs) support patients and work alongside healthcare professionals throughout the care pathway. Skin cancer management is rapidly evolving, with increasing and more complex treatment options now available, so the need for patient support is growing. While SCSNs are a major source of that support, the provision of SCSN resource across the UK has never previously been assessed. We therefore undertook a first SCSN census on 1st June 2021. METHODS: An electronic survey was disseminated to UK hospital trusts and registered skin cancer healthcare professionals. Responses were identifiable only by the respective trust name. RESULTS: 112 responses from 87 different secondary care trusts were received; 92% of trusts reporting having at least 1 established SCSN post. Average SCSN staffing per trust was 2.4 (range 0–7) whole time equivalents, managing an average caseload of 83 (range 6–400) patients per week. SCSN workload had increased in 82% hospitals in the previous year and 30% of trusts reported being under-resourced. Most SCSN time was spent managing melanoma (as opposed to non-melanoma skin cancer) patients linked to surgical services. Regional variations existed, particularly associated with provision of lymphoedema services, nurse prescribing skills and patient access to clinical trials. The COVID-19 pandemic was associated with a marked increase in SCSN-led telemedicine clinics, but loss of training and education opportunities. CONCLUSIONS: SCSNs based in secondary care hospitals play a major role supporting both clinicians and patients throughout the care pathway. This first UK census confirmed that SCSN workload is increasing and in one third of hospital trusts, the work was reported to outstrip the staffing available to manage the volume of work. Regional variations in SCSN resource, workload and job role, as well as availability of certain skin cancer services were identified, providing valuable information to healthcare commissioners concerned with service improvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12912-023-01374-x. BioMed Central 2023-06-25 /pmc/articles/PMC10290789/ /pubmed/37355649 http://dx.doi.org/10.1186/s12912-023-01374-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Rammanohar, Jashmitha Kotecha, Deeya Hodgetts, Jackie Reeken, Saskia Daniels, Susanna Corrie, Pippa G A first census of skin cancer specialist nurses across UK secondary care trusts |
title | A first census of skin cancer specialist nurses across UK secondary care trusts |
title_full | A first census of skin cancer specialist nurses across UK secondary care trusts |
title_fullStr | A first census of skin cancer specialist nurses across UK secondary care trusts |
title_full_unstemmed | A first census of skin cancer specialist nurses across UK secondary care trusts |
title_short | A first census of skin cancer specialist nurses across UK secondary care trusts |
title_sort | first census of skin cancer specialist nurses across uk secondary care trusts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290789/ https://www.ncbi.nlm.nih.gov/pubmed/37355649 http://dx.doi.org/10.1186/s12912-023-01374-x |
work_keys_str_mv | AT rammanoharjashmitha afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT kotechadeeya afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT hodgettsjackie afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT reekensaskia afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT danielssusanna afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT corriepippag afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT rammanoharjashmitha firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT kotechadeeya firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT hodgettsjackie firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT reekensaskia firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT danielssusanna firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts AT corriepippag firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts |